Cutaneous coagulation clues for COVID-19, botulinum toxin's antidepressant effect, tape strips over biopsy, and a conversation on academic derm in a pandemic

COVID-19 has had profound effects on the financial stability of academic institutions, resident training, and patient care. Candrice Heath, MD (@DrCandriceHeath) talks to Erin Boh, MD, and Dirk Elston, MD, about emergency response plans in the academic setting as well as how institutions have been using teledermatology and managing resident education.

“Our institution is doing quite well because we’ve actually jumped headlong and feetfirst into COVID research. . . . Our research dollars have increased double percentwise because of that," Dr. Boh said.

*  *  *

This week in dermatology news:

1. Cutaneous clues linked to COVID-19 coagulation risk: https://bit.ly/31Ik4Ne
   Research letter: https://bit.ly/3kCnWIn
   Skin manifestations of COVID-19: https://bit.ly/2XUonnL
2. Study highlights potential advantages of tape strips over biopsy: https://bit.ly/33TTZxi
   Original source: https://bit.ly/30R4WOm
3. Botulinum toxin associated with antidepressant effects across indications, injection sites: https://bit.ly/2XVMd2m
   Original source: https://go.nature.com/3kGM38y

*  *  *

Hosts: Nick Andrews; Candrice R. Heath, MD (Temple University Hospital, Philadelphia)

Guests: Erin Boh, MD, PhD (Tulane University, New Orleans); Dirk M. Elston, MD (Medical University of South Carolina, Charleston)

Disclosures: Dr. Heath, Dr. Boh, and Dr. Elston report no conflicts of interest.

Show notes by: Alicia Sonners, Melissa Sears

*  *  *

You can find more of our podcasts at http://www.mdedge.com/podcasts      

Email the show: podcasts@mdedge.com

Interact with us on Twitter: @MDedgeDerm